Quadrilateral Space Syndrome

Quadrilateral space syndrome (QSS), also written quadrangular space syndrome, is a relatively rare condition in which the axillary nerve and the posterior circumflex humeral artery (PCHA) are compressed as they pass through the quadrilateral space of the posterior shoulder. The result is a constellation of poorly localised symptoms - posterolateral shoulder pain, paraesthesia in a non-dermatomal pattern, and sometimes deltoid or teres minor weakness - that overlap with much more common shoulder problems.

The condition was first described in the early 1980s and remains uncommon, which is exactly why it is a high-yield exam trap: it is the diagnosis you reach only after excluding rotator cuff disease, suprascapular neuropathy, and cervical radiculopathy.

Key epidemiological points:

• True compressive QSS is rare; large MRI series show that isolated teres minor atrophy is far more often explained by cuff disease or idiopathic traction than by genuine compression.
• The neurogenic subtype is the more common presentation; the vascular subtype is rarer but can be limb-threatening.
• Because the syndrome is uncommon and the symptoms are vague, diagnostic delay is the rule, and many patients are treated for presumed cuff or cervical pathology first.

The quadrilateral space is a four-sided gap in the posterior shoulder bounded by:

• Superior: teres minor
• Inferior: teres major
• Medial: long head of triceps brachii
• Lateral: surgical neck of the humerus

Its two contents - the axillary nerve and the posterior circumflex humeral artery - are the structures at risk in QSS.

Why compression happens. The space is dynamic. During abduction and external rotation - the throwing cocking position - the borders crowd together and the cross-sectional area of the quadrilateral space falls. In repetitive overhead athletes, hypertrophy of the surrounding muscles and the development of fibrous bands (most often between the teres muscles and the long head of triceps) narrow the space further and tether the neurovascular bundle.

Neurogenic pathophysiology. Chronic compression or traction of the axillary nerve produces a focal neuropathy. Because the teres minor branch is often involved, isolated teres minor denervation and fatty atrophy is the classic (though non-specific) imaging hallmark. More severe compression of the main axillary nerve also denervates the deltoid.

Vascular pathophysiology. Repetitive compression of the PCHA against fibrous bands or the humerus causes intimal injury, which can lead to thrombosis, aneurysm formation, and distal embolisation. The clinical result may be digital ischaemia, splinter haemorrhages, or cold intolerance in the dominant hand of a young athlete - a presentation that is easy to miss if QSS is not considered.

QSS is most usefully classified by the predominant compressed structure, because this drives both the presentation and the management.

History. Ask about the sport and the dominant arm. The typical patient is a young overhead athlete with insidious, poorly localised posterolateral shoulder pain that is worse with the arm abducted and externally rotated, and who may describe paraesthesia down the lateral arm that does not follow a dermatome. In the vascular subtype, ask specifically about cold hands, colour change, and finger pain.

Examination.

• Inspection: look for deltoid or teres minor wasting in chronic cases (often subtle).
• Palpation: point tenderness over the quadrilateral space, felt just lateral to the lateral scapular border, is a useful (if non-specific) sign.
• Provocation: holding the arm in abduction and external rotation for about one minute reproduces the pain and paraesthesia.
• Neurology: test deltoid and teres minor power and the regimental-badge sensory patch over the lateral deltoid.
• Vascular: check distal pulses, capillary refill, and inspect the fingertips for emboli or splinter haemorrhages.

There is no single diagnostic test for QSS; the workup is built to exclude mimics and to support the clinical impression.

Plain radiographs - usually normal; obtained to exclude bony lesions (osteochondroma), old fracture, or calcification.

MRI - the most useful single test. Look for:

• Teres minor denervation / fatty atrophy (sensitive but not specific)
• Deltoid denervation in more advanced axillary nerve involvement
• Space-occupying lesions - paralabral cyst, mass, or PCHA aneurysm

Ultrasound - increasingly used; can dynamically assess the PCHA during abduction-external rotation with colour Doppler and can guide a diagnostic block.

Electromyography / nerve conduction studies - may show axillary neuropathy and help exclude suprascapular and cervical causes, but can be normal in early or purely vascular disease.

Angiography (CT, MR or catheter) - reserved for suspected vascular QSS; dynamic imaging in abduction-external rotation may be required to demonstrate PCHA occlusion or aneurysm that is not seen in the neutral position.

Image-guided quadrilateral space / axillary nerve block - meaningful pain relief after a local anaesthetic block within the quadrilateral space, in the right clinical context, is one of the most useful confirmatory findings.

Management is stepwise and depends on subtype. The default for neurogenic QSS is a prolonged non-operative trial; the threshold for early surgery is much lower in vascular disease or when a structural lesion is found.

Complications of the condition (untreated or progressive):

• Persistent posterolateral shoulder pain and loss of overhead performance
• Progressive axillary neuropathy with teres minor and deltoid weakness/atrophy
• Vascular: PCHA thrombosis, aneurysm, and distal embolisation causing digital ischaemia - potentially limb-threatening

Complications of surgical decompression:

• Iatrogenic axillary nerve injury (the very structure being protected)
• Injury to the posterior circumflex humeral vessels with bleeding or haematoma
• Incomplete decompression with persistent symptoms
• Recurrence (e.g. paralabral cyst recurrence if the labral tear is not addressed)
• Standard wound complications - infection, stiffness

Rehabilitation after decompression is staged and prioritises early protected motion with progressive return to overhead loading.

In published case material, athletes who undergo decompression for refractory neurogenic QSS can regain deltoid bulk and strength and return to full sport, with restoration of muscle mass and durable relief reported over months to a couple of years of follow-up.

The evidence base is limited to small case series and case reports (Level 4), so prognostic statements must be cautious.

• Non-operative: many overhead athletes with neurogenic QSS improve with load management and rehabilitation, which is why a prolonged trial is recommended first.
• Surgical decompression: small series report good symptom relief and return to sport in appropriately selected refractory neurogenic cases.
• Vascular QSS: with timely diagnosis and combined vascular and decompressive surgery, distal ischaemia can be salvaged and baseline function restored; delay risks permanent tissue loss.
• Prognostic caveat: outcomes are best when the diagnosis is genuine. Operating on non-specific teres minor atrophy without a coherent clinical picture predicts a poor result.

According to PubMed, the following sources inform current understanding of quadrilateral space syndrome.

There are no formal society guidelines or registries specific to quadrilateral space syndrome - it is too rare, and the literature is Level 4 (case series and reports). Practice is therefore consensus-based and consistent across regions.

Points of global consensus:

• QSS is a diagnosis of exclusion; rule out the common shoulder mimics first (rotator cuff disease, suprascapular neuropathy, cervical radiculopathy).
• MRI is the primary imaging test worldwide; dynamic ultrasound is a useful, inexpensive, widely available adjunct for the neurovascular bundle and for guided blocks.
• A positive image-guided quadrilateral space block is a widely accepted supportive test where the diagnosis is uncertain.
• Non-operative care for at least 6 months is the accepted first-line for neurogenic disease; surgical decompression is reserved for refractory or structural disease.
• The vascular subtype is managed jointly with vascular surgery, with endovascular therapy for acute ischaemia - a pathway that depends on local interventional radiology and vascular surgery availability.

Practice variation: access to dynamic angiography, musculoskeletal ultrasound, and catheter-directed endovascular therapy differs by resource setting, which influences how quickly the vascular subtype is diagnosed and treated.